valine has been researched along with ganciclovir in 73 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 16 (21.92) | 18.2507 |
2000's | 36 (49.32) | 29.6817 |
2010's | 21 (28.77) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Darby, G | 1 |
Schacke, M; Thust, R; Wutzler, P | 1 |
Reusser, P | 1 |
Bowen, EF; Davey, CC; Emery, VC; Griffiths, PD; Johnson, MA | 1 |
Itin, PH; Lautenschlager, S | 1 |
Ganem, D; Kedes, DH | 1 |
Chou, S; Drew, WL; Gordon, SM; LaVoy, AG; Marousek, G; Miner, RC; Parenti, DM; Ross, JG | 1 |
Kuypers, DR; Vanrenterghem, YF | 1 |
Keating, MR | 1 |
Beresford, JA; Grigg, A; Matthews, JP; Sasadeusz, J; Steer, CB; Szer, J | 1 |
Adler, HL; Aguilar-Cordova, E; Butler, EB; Herman, JR; Kadmon, D; Miles, BJ; Scardino, PT; Shalev, M; Teh, BS; Thompson, TC | 1 |
Legendre, C | 1 |
Annemans, L; Maclaine, G; Mauskopf, JA; Richter, A | 1 |
Cheng, B | 1 |
Torres, G | 1 |
Spector, SA | 1 |
Feinberg, J | 1 |
De Clercq, E; Naesens, L | 1 |
Field, HJ; Gürr, WK; Littler, E; Shaw, MM; Thackray, AM; Watts, PA | 1 |
Zaia, JA | 1 |
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M | 1 |
Bouda, M; Jindra, P; Opatrny, K; Reischig, T; Svecova, M; Treska, V | 1 |
Chandrasekar, PH; Petersen, FB; Snydman, DR; Territo, MC; Winston, DJ; Yeager, AM | 1 |
Beaulieu, J; Dworkin, L; Gohh, R; Monaco, A; Morrissey, P; Shemin, D; Yango, A; Zanabli, A | 1 |
Bloom, JW; Carlsson, P; Carlstedt-Duke, J; Kunz, S; Miesfeld, RL; Sandoval, R | 1 |
Amato, R; Ayala, G; Butler, EB; Fujita, T; Gdor, Y; Kadmon, D; Kusaka, N; Mai, WY; Miles, BJ; Pramudji, CK; Satoh, T; Teh, BS; Thompson, TC; Timme, TL; Vlachaki, MT; Wheeler, T | 1 |
Alain, S; Champier, G; Cogne, N; De Wilde, A; Denis, F; Fillet, AM; Gouarin, S; Hantz, S; Imbert, BM; Karras, A; Legendre, C; Mazeron, MC; Mengelle, C; Rogez, S; Scieux, C; Szelag, JC | 1 |
Ioannidis, J; Wilkinson, D | 1 |
Cechura, M; Hes, O; Jindra, P; Mares, J; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
Guex-Crosier, Y; Meylan, PR | 1 |
Alain, S; Bensman, A; Champier, G; Dehee, A; Denis, F; Fillet, AM; Guigonis, V; Hantz, S; Mazeron, MC; Mertens, T; Michel, D | 1 |
Dediulescu, DF; Dediulescu, L | 1 |
Morton, CJ; Ng, HL; Parker, MW; Rawlinson, WD; Scott, GM | 1 |
Jindra, P; Mares, J; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
Chan, KP; Kumarasinghe, G; Yap, HK; Yeo, AC | 1 |
Boletis, JN; Chelioti, H; Daikos, GL; Kostakis, A; Pavlopoulou, ID; Stamatiades, D; Syriopoulou, VP | 1 |
Barclay, PG; Craig, JC; Hodson, EM; Jones, C; Kable, K; Strippoli, GF; Vimalachandra, D; Webster, AC | 1 |
Brandl, M; Stefanidis, D | 1 |
Chen, L; Ng, AP; Prince, HM; Seymour, JF; Slavin, M; Thursky, K; Worth, L | 1 |
Artz, A; Godley, L; Kline, J; Larson, RA; Pollyea, DA; Pursell, K; Rich, E; Stock, W; Thompson, K; van Besien, K; Zimmerman, T | 1 |
Jindra, P; Kormunda, S; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
Falagas, ME; Vardakas, KZ | 1 |
Chihara, H; Hara, Y; Inatomi, T; Kawasaki, S; Kinoshita, S; Koizumi, N; Mochida, C; Ohashi, Y; Shiraishi, A; Sotozono, C; Suzuki, T; Uno, T; Yamasaki, K | 1 |
Hes, O; Jindra, P; Klaboch, J; Reischig, T; Svecová, M; Treska, V | 1 |
Amidon, GL; Lai, L; Lee, KD; Xu, Z; Zhou, J | 1 |
Craig, JC; Hodson, EM; Strippoli, GF; Webster, AC | 1 |
Smolej, L | 1 |
Croubels, S; De Backer, P; Desmet, N; Garré, B; Maes, A; Nauwynck, H; van der Meulen, K | 1 |
Baglivo, E; Gervaix, A; Wimmersberger, Y | 1 |
Bowlin, TL; Drach, JC; Prichard, MN; Wu, Z; Yanachkov, I; Yanachkova, M; Zemlicka, J | 1 |
Bouda, M; Hes, O; Jindra, P; Nemcová, J; Reischig, T; Treska, V; Vanecek, T | 1 |
Akl, A; Blancho, G; Cantarovich, D; Dantal, J; Giral, M; Leone, F; Soulillou, JP | 1 |
Aydinli, B; Bilen, Y; Cetinkaya, R; Keles, M; Polat, KY; Turkmen, M; Uyanik, A; Yildirim, R | 1 |
Chiang, CC; Lin, TH; Tien, PT; Tsai, YY | 1 |
Khuroo, A; Mishra, S; Monif, T; Saxena, S; Singh, O | 1 |
Razonable, RR | 1 |
Charkoudian, LD; Kaiser, GM; Srivastava, SK; Steinmetz, RL | 1 |
Reischig, T | 1 |
Bouda, M; Jindra, P; Lysak, D; Matejovic, M; Prucha, M; Reischig, T; Sedlackova, L | 1 |
Abdulbaki, A; Aoun, EG; Baidoo, L; Hashash, JG; Refaat, M | 1 |
Bouda, M; Jindra, P; Kielberger, L; Reischig, T | 1 |
Brennan, DC; Santos, RD | 1 |
Bouda, M; Hes, O; Hribova, P; Jindra, P; Reischig, T; Treska, V; Viklicky, O | 1 |
Alexopoulos, SP; Lindberg, L; Matsuoka, L; Subramanyan, RK | 1 |
Cunningham, ET; Fu, A; Johnson, RN; Jumper, JM; Lujan, BJ; McDonald, HR; Wong, RW | 1 |
Craig, JC; Hodson, EM; Ladhani, M; Strippoli, GF; Webster, AC | 1 |
Beersma, MF; Bouts, AH; Cornelissen, EA; Cransberg, K; Jongsma, H | 1 |
Dong, LQ; Guan, LB; Li, SF; Wang, W; Yu, P; Zhang, L; Zhang, P; Zhou, S | 1 |
Bouda, M; Hes, O; Jindra, P; Kacer, M; Lysak, D; Reischig, T | 1 |
Bouda, M; Kacer, M; Kielberger, L; Reischig, T | 1 |
16 review(s) available for valine and ganciclovir
Article | Year |
---|---|
Acyclovir--and beyond.
Topics: Acyclovir; Arabinofuranosyluracil; Cytomegalovirus Infections; Ganciclovir; Guanine; Herpes Simplex; Herpesvirus 3, Human; Humans; Valacyclovir; Valine | 1994 |
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine | 1996 |
Lessons from the natural history of cytomegalovirus.
Topics: Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Ganciclovir; Humans; Polymerase Chain Reaction; Risk Factors; Valacyclovir; Valine | 1996 |
Viral lesions of the mouth in HIV-infected patients.
Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts | 1997 |
Prophylaxis of cytomegalovirus infection in renal transplantation: new data for an old problem.
Topics: Acyclovir; Antiviral Agents; Clinical Trials as Topic; Cytomegalovirus Infections; Ganciclovir; Humans; Kidney Transplantation; Postoperative Complications; Valacyclovir; Valine | 1999 |
Antiviral agents for non-human immunodeficiency virus infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir | 1999 |
Recent developments in herpesvirus therapy.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine | 2001 |
[Drugs against human cytomegalovirus].
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine | 2002 |
HIV: opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Antitubercular Agents; Antiviral Agents; Atovaquone; Azithromycin; Chickenpox; Clarithromycin; Cytomegalovirus Infections; Drug Therapy, Combination; Ganciclovir; Herpes Simplex; Humans; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Pneumonia, Pneumocystis; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Tuberculosis, Pulmonary; Valacyclovir; Valine | 2003 |
[Antiherpetic therapy].
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine | 2005 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valacyclovir; Valine | 2005 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valine | 2008 |
Antiviral drugs for viruses other than human immunodeficiency virus.
Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir | 2011 |
Advances in cytomegalovirus-preventive strategies in solid organ transplantation: defending pre-emptive therapy.
Topics: Acyclovir; Antiviral Agents; Clinical Protocols; Cytomegalovirus Infections; Ganciclovir; Humans; Immunosuppressive Agents; Opportunistic Infections; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valganciclovir; Valine | 2012 |
Emerging concepts in the management of acute retinal necrosis.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Retinitis; Eye Infections, Viral; Famciclovir; Fluorescein Angiography; Ganciclovir; Herpes Simplex; Humans; Laser Coagulation; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valganciclovir; Valine | 2013 |
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Randomized Controlled Trials as Topic; Valacyclovir; Valine | 2013 |
17 trial(s) available for valine and ganciclovir
Article | Year |
---|---|
Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir.
Topics: 2-Aminopurine; Acyclovir; Adolescent; Adult; Age of Onset; Aged; Analysis of Variance; Antiviral Agents; Bone Marrow Transplantation; Chickenpox; Dose-Response Relationship, Drug; Enzyme Activation; Famciclovir; Female; Ganciclovir; Graft vs Host Disease; Herpes Zoster; Herpesvirus 3, Human; Humans; Incidence; Male; Middle Aged; Prodrugs; Retrospective Studies; Risk Factors; Skin Diseases; Transplantation, Homologous; Valacyclovir; Valine | 2000 |
Opportunistic infection highlights from the 35th ICAAC.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bacterial Vaccines; CD4 Lymphocyte Count; Cidofovir; Clinical Trials as Topic; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Ganciclovir; HIV; Humans; Influenza Vaccines; Mycobacterium avium-intracellulare Infection; Organophosphonates; Organophosphorus Compounds; Pneumonia; Pneumonia, Pneumocystis; Randomized Controlled Trials as Topic; United States; Valacyclovir; Valine; Viremia | 1995 |
Ganciclovir studies leave clinicians confused.
Topics: Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Ganciclovir; Humans; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; Valacyclovir; Valine | 1995 |
A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cadaver; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Ganciclovir; Humans; Kidney Diseases; Kidney Transplantation; Living Donors; Male; Middle Aged; Postoperative Complications; Prospective Studies; Renal Insufficiency; Tissue Donors; Valacyclovir; Valine | 2002 |
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Sepsis; Survival Analysis; Transplantation, Homologous; Valacyclovir; Valine | 2003 |
Enhanced systemic T-cell activation after in situ gene therapy with radiotherapy in prostate cancer patients.
Topics: Acyclovir; Adenoviridae; Adult; Aged; Aged, 80 and over; Antiviral Agents; Avian Sarcoma Viruses; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Combined Modality Therapy; Ganciclovir; Genetic Therapy; Humans; Lymphocyte Activation; Male; Middle Aged; Prodrugs; Prostatectomy; Prostatic Neoplasms; Thymidine Kinase; Valacyclovir; Valine | 2004 |
Valacyclovir for cytomegalovirus prophylaxis reduces the risk of acute renal allograft rejection.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Reoperation; Risk Factors; Survival Analysis; Time Factors; Transplantation, Homologous; Valacyclovir; Valine | 2005 |
Prospective comparison of valacyclovir and oral ganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Health Care Costs; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Risk Factors; Valacyclovir; Valine; Viremia | 2005 |
A comparative randomised study of valacyclovir vs. oral ganciclovir for cytomegalovirus prophylaxis in renal transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Antiviral Agents; Costs and Cost Analysis; Cytomegalovirus Infections; Female; Ganciclovir; Greece; Humans; Kidney Transplantation; Male; Postoperative Complications; Valacyclovir; Valine | 2005 |
Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning.
Topics: Acyclovir; Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Female; Ganciclovir; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous; Valacyclovir; Valine | 2006 |
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Carrier State; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Valacyclovir; Valine | 2006 |
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; Ganciclovir; Humans; Incidence; Kidney Transplantation; Middle Aged; Prospective Studies; Valacyclovir; Valganciclovir; Valine | 2008 |
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Ganciclovir; Graft Rejection; Humans; Kidney Transplantation; Postoperative Complications; Premedication; Risk Factors; Transplantation, Homologous; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viremia | 2010 |
Determination of valganciclovir and ganciclovir in human plasma by liquid chromatography tandem mass spectrometric detection.
Topics: Acyclovir; Calibration; Chromatography, Liquid; Drug Stability; Ganciclovir; Humans; Reproducibility of Results; Tandem Mass Spectrometry; Time Factors; Valacyclovir; Valganciclovir; Valine | 2011 |
Pharmacoeconomic impact of different regimens to prevent cytomegalovirus infection in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Economics, Pharmaceutical; Female; Ganciclovir; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prospective Studies; Valacyclovir; Valine | 2012 |
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Atrophy; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrosis; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2012 |
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Biomarkers; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; DNA, Viral; Drug Administration Schedule; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viral Load | 2015 |
40 other study(ies) available for valine and ganciclovir
Article | Year |
---|---|
Cytogenetic genotoxicity of antiherpes virostatics in Chinese hamster V79-E cells. I. Purine nucleoside analogues.
Topics: 2-Aminopurine; Acyclovir; Animals; CHO Cells; Cricetinae; Famciclovir; Ganciclovir; Guanine; Mutagenicity Tests; Mutagens; Valacyclovir; Valine | 1996 |
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication | 1997 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases | 1997 |
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Reverse Transcriptase Inhibitors; Valine; Viral Proteins | 1998 |
Suicide gene therapy toxicity after multiple and repeat injections in patients with localized prostate cancer.
Topics: Acyclovir; Adenoviridae; Antiviral Agents; Clinical Trials as Topic; Defective Viruses; Ganciclovir; Genetic Therapy; Genetic Vectors; Humans; Injections, Intralesional; Male; Prostatic Neoplasms; Simplexvirus; Thymidine Kinase; Valacyclovir; Valine; Virus Replication | 2000 |
Drugs for non-HIV viral infections.
Topics: 2-Aminopurine; Acetamides; Acyclovir; Aged; Amantadine; Animals; Anti-HIV Agents; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Enzyme Inhibitors; Famciclovir; Ganciclovir; Guanidines; Guanine; Herpes Simplex; Herpes Zoster; History, 18th Century; HIV Infections; Humans; Injections, Intravenous; Interferon-alpha; Lamivudine; Neuraminidase; Oseltamivir; Pyrans; Rats; Ribavirin; Sialic Acids; Teratogens; Valacyclovir; Valine; Zanamivir | 1999 |
Ganciclovir-resistant cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Ganciclovir; Humans; Organ Transplantation; Postoperative Complications; Valacyclovir; Valine | 2000 |
Cost-effectiveness model of cytomegalovirus management strategies in renal transplantation. Comparing valaciclovir prophylaxis with current practice.
Topics: Acyclovir; Administration, Oral; Algorithms; Antiviral Agents; Cost-Benefit Analysis; Cytomegalovirus Infections; Decision Trees; Drug Costs; Ganciclovir; Humans; Injections, Intravenous; Kidney Transplantation; Postoperative Complications; Premedication; Valacyclovir; Valine; Virus Shedding | 2000 |
Preventing opportunistic infections.
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Clarithromycin; Clindamycin; Clinical Trials as Topic; Clotrimazole; Cytomegalovirus Infections; Dapsone; Fluconazole; Ganciclovir; Humans; Itraconazole; Leucovorin; Mycobacterium avium-intracellulare Infection; Mycoses; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Rifabutin; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination; Valacyclovir; Valine | 1995 |
Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine | 1996 |
The status of CMV viral load testing.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; HIV Infections; Humans; Polymerase Chain Reaction; Prospective Studies; Valacyclovir; Valine; Viral Load; Viremia | 1996 |
Temporal pattern of herpes simplex virus type 1 infection and cell death in the mouse brain stem: influence of guanosine nucleoside analogues.
Topics: 2-Aminopurine; Acyclovir; Animals; Antiviral Agents; Apoptosis; Brain Stem; Disease Models, Animal; DNA Fragmentation; Famciclovir; Female; Ganciclovir; Guanine; Herpes Simplex; Herpesvirus 1, Human; Humans; In Situ Nick-End Labeling; Mice; Mice, Inbred BALB C; Valacyclovir; Valine | 2002 |
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine | 2002 |
Comparative study of prophylactic oral ganciclovir and valacyclovir in high-risk kidney transplant recipients.
Topics: Acyclovir; Administration, Oral; Adult; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Ganciclovir; Graft Rejection; Graft Survival; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Opportunistic Infections; Preoperative Care; Probability; Retrospective Studies; Risk Assessment; Treatment Outcome; Valacyclovir; Valine | 2003 |
Identification of a novel glucocorticoid receptor mutation in budesonide-resistant human bronchial epithelial cells.
Topics: Amino Acid Sequence; Amino Acid Substitution; Base Sequence; Binding Sites; Bronchi; Budesonide; Carcinoma, Bronchogenic; Cell Line; Cell Line, Tumor; Drug Resistance; Ganciclovir; Glutathione Transferase; Humans; Lung Neoplasms; Methionine; Molecular Sequence Data; Mucous Membrane; Mutation, Missense; Receptors, Glucocorticoid; Recombinant Fusion Proteins; Respiratory Mucosa; Transfection; Valine | 2003 |
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Chemoprevention; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Pilot Projects; Retrospective Studies; Valacyclovir; Valine; Viral Matrix Proteins | 2004 |
High dosage of oral valaciclovir as an alternative treatment of varicella zoster acute retinal necrosis syndrome.
Topics: Acyclovir; Antiviral Agents; Eye Infections, Viral; Ganciclovir; Herpes Zoster; Humans; Retinal Necrosis Syndrome, Acute; Valacyclovir; Valganciclovir; Valine | 2006 |
Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Topics: Acyclovir; Adolescent; Antiviral Agents; Chemoprevention; Codon; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Kidney Transplantation; Molecular Sequence Data; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Sequence Deletion; Valacyclovir; Valine | 2005 |
Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Ganciclovir; Guanine; Humans; Mice; Models, Molecular; Molecular Sequence Data; Muromegalovirus; Mutation; Organophosphonates; Protein Kinases; Sequence Alignment; Valacyclovir; Valine; Virus Replication | 2005 |
Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons.
Topics: Amino Acid Substitution; Antiviral Agents; Codon; Cytomegalovirus; DNA, Viral; Drug Resistance, Viral; Ganciclovir; Humans; Methionine; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Valine | 2005 |
Reactivity of valganciclovir in aqueous solution.
Topics: Buffers; Chromatography, High Pressure Liquid; Ganciclovir; Half-Life; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Solutions; Stereoisomerism; Valganciclovir; Valine | 2005 |
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Topics: Acyclovir; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cohort Studies; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Diphtheria Toxin; DNA, Viral; Doxorubicin; Female; Fever; Follow-Up Studies; Ganciclovir; Hematologic Neoplasms; Humans; Interleukin-2; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Retrospective Studies; Rituximab; Transplantation, Autologous; Valacyclovir; Valine; Vidarabine; Vincristine; Viremia; Virus Activation | 2005 |
Anti-cytomegalovirus prophylaxis in solid-organ transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Organ Transplantation; Valacyclovir; Valganciclovir; Valine | 2006 |
Cytomegalovirus as an etiologic factor in corneal endotheliitis.
Topics: Acyclovir; Administration, Topical; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cell Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Eye Infections, Viral; Female; Ganciclovir; Humans; Keratitis; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valacyclovir; Valine | 2008 |
Molecular basis of prodrug activation by human valacyclovirase, an alpha-amino acid ester hydrolase.
Topics: Acyclovir; Animals; Antiviral Agents; Binding Sites; Carboxylic Ester Hydrolases; Crystallography, X-Ray; Ganciclovir; Humans; Hydrophobic and Hydrophilic Interactions; Mutation; Phylogeny; Prodrugs; Protein Structure, Tertiary; Valacyclovir; Valganciclovir; Valine | 2008 |
Valganciclovir versus valaciclovir for prevention of alemtuzumab-induced cytomegalovirus reactivation: what are the implications for routine clinical practice?
Topics: Acyclovir; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Agents; Antiviral Agents; Cytomegalovirus Infections; Ganciclovir; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Valacyclovir; Valganciclovir; Valine | 2008 |
Determination of acyclovir in horse plasma and body fluids by high-performance liquid chromatography combined with fluorescence detection and heated electrospray ionization tandem mass spectrometry.
Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Body Fluids; Chromatography, High Pressure Liquid; Fluorescence; Ganciclovir; Horses; Infusions, Intravenous; Linear Models; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Valacyclovir; Valine | 2009 |
VZV retinal vasculitis without systemic infection: diagnosis and monitoring with quantitative Polymerase Chain Reaction.
Topics: Acyclovir; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Administration Routes; Eye Infections, Viral; Female; Ganciclovir; Herpesvirus 3, Human; Humans; Photophobia; Polymerase Chain Reaction; Retinal Vasculitis; Treatment Outcome; Valacyclovir; Valine; Vision, Low | 2010 |
L-valine ester of cyclopropavir: a new antiviral prodrug.
Topics: Animals; Antiviral Agents; Biological Availability; Cyclopropanes; Cytomegalovirus; Esters; Ganciclovir; Guanine; Humans; Hydrolysis; Mice; Prodrugs; Valganciclovir; Valine; Virus Replication | 2009 |
Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Incidence; Injections, Intravenous; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Prodrugs; Retrospective Studies; Survival Rate; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2010 |
Neutropenia related to valacyclovir and valganciclovir in 2 renal transplant patients and treatment with granulocyte colony stimulating factor: a case report.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus Infections; Filgrastim; Ganciclovir; Granulocyte Colony-Stimulating Factor; Humans; Kidney Transplantation; Male; Neutropenia; Recombinant Proteins; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2010 |
Atypical presentation of cytomegalovirus endotheliitis: a case report.
Topics: Acyclovir; Aged; Antiviral Agents; Corneal Edema; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Ganciclovir; Humans; Intraocular Pressure; Keratitis, Herpetic; Male; Prednisolone; Valacyclovir; Valganciclovir; Valine; Visual Acuity | 2011 |
Acute retinal necrosis after herpes zoster vaccination.
Topics: Acyclovir; Aged; Aged, 80 and over; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Ganciclovir; Herpes Zoster Ophthalmicus; Herpes Zoster Vaccine; Herpesvirus 3, Human; Humans; Male; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Vaccination; Valacyclovir; Valine; Visual Acuity | 2011 |
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cell Proliferation; Cells, Cultured; Concanavalin A; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Phytohemagglutinins; T-Lymphocyte Subsets; Valacyclovir; Valganciclovir; Valine | 2011 |
Cytomegalovirus colitis.
Topics: Acyclovir; Antiviral Agents; Azathioprine; Colitis; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Immunosuppressive Agents; Valacyclovir; Valine; Young Adult | 2012 |
Randomized trial of pre-emptive or prophylactic valganciclovir therapy for prevention of cytomegalovirus infection in renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Valacyclovir; Valganciclovir; Valine | 2012 |
Cytomegalovirus prophylaxis in solid organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Risk Factors; Tissue Transplantation; Valacyclovir; Valganciclovir; Valine | 2012 |
Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ganciclovir; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Kidney Transplantation; Netherlands; Polymerase Chain Reaction; Receptors, Interleukin-2; Renal Insufficiency; Retrospective Studies; Risk; Valacyclovir; Valganciclovir; Valine | 2013 |
Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.
Topics: Acyclovir; Adult; Allografts; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valine | 2013 |
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valganciclovir; Valine | 2015 |